{
    "ticker": "CMRX",
    "name": "Chimerix, Inc.",
    "description": "Chimerix, Inc. is a biotechnology company dedicated to the discovery, development, and commercialization of antiviral therapeutics. Founded in 2000 and based in Durham, North Carolina, Chimerix is at the forefront of addressing critical unmet medical needs in patients with serious viral infections. The company's lead product candidate, brincidofovir, is a novel oral antiviral drug designed to treat cytomegalovirus (CMV) infections in immunocompromised patients, including those undergoing stem cell transplants. Chimerix's proprietary drug development platform allows for the exploration of a range of antiviral compounds targeting a spectrum of viral pathogens. The company is committed to advancing treatments that can significantly improve patient outcomes and quality of life. With a robust pipeline and a focus on innovative solutions, Chimerix aims to be a leader in the antiviral therapeutics space, addressing complex challenges posed by viral diseases. Their mission encompasses not only developing effective treatments but also ensuring accessibility and affordability for patients globally.",
    "industry": [
        "Biotechnology",
        "Pharmaceuticals"
    ],
    "headquarters": "Durham, North Carolina, USA",
    "founded": "2000",
    "website": "https://www.chimerix.com",
    "ceo": "Mike Sherman",
    "social_media": {
        "twitter": "https://twitter.com/chimerix",
        "linkedin": "https://www.linkedin.com/company/chimerix"
    },
    "investor_relations": "https://investors.chimerix.com",
    "key_executives": [
        {
            "name": "Mike Sherman",
            "position": "CEO"
        },
        {
            "name": "Duncan Moore",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Antiviral Therapeutics",
            "products": [
                "Brincidofovir"
            ]
        }
    ],
    "seo": {
        "meta_title": "Chimerix, Inc. | Innovating Antiviral Therapeutics",
        "meta_description": "Explore Chimerix, Inc., a biotechnology company focused on developing antiviral drugs for serious infections. Learn about their innovative therapies and mission.",
        "keywords": [
            "Chimerix",
            "Biotechnology",
            "Antiviral",
            "Cytomegalovirus",
            "Pharmaceuticals",
            "Brincidofovir"
        ]
    },
    "faq": [
        {
            "question": "What is Chimerix known for?",
            "answer": "Chimerix is known for its development of antiviral therapeutics, particularly for serious viral infections."
        },
        {
            "question": "Who is the CEO of Chimerix?",
            "answer": "Mike Sherman is the CEO of Chimerix, Inc."
        },
        {
            "question": "Where is Chimerix headquartered?",
            "answer": "Chimerix is headquartered in Durham, North Carolina, USA."
        },
        {
            "question": "What is Chimerix's main product?",
            "answer": "Chimerix's main product is brincidofovir, an antiviral drug for treating cytomegalovirus."
        },
        {
            "question": "When was Chimerix founded?",
            "answer": "Chimerix was founded in 2000."
        }
    ],
    "competitors": [
        "GILD",
        "VRNA",
        "AXSM",
        "VIR"
    ],
    "related_stocks": [
        "AMGN",
        "BIIB",
        "REGN",
        "VRTX"
    ]
}